Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Lenz Robert A.
Head of R&D at Neumora Therapeutics. Filing since 12 Sep 2024.
CIK 0001992908
Company
Date
Role
Action
Shares
Amount
Of holding
NMRA
Neumora Therapeutics, Inc.
18 Feb 2025
Head of R&D
Sold on a plan
5,614
$9.38K
1.8%
NMRA
Neumora Therapeutics, Inc.
10 Oct 2024
Head of R&D
Sold on a plan
8,260
$124.60K
2.6%
NMRA
Neumora Therapeutics, Inc.
9 Oct 2024
Head of R&D
Sold on a plan
5,563
$83.51K
1.7%
NMRA
Neumora Therapeutics, Inc.
18 Sep 2024
Head of R&D
Sold on a plan
10,676
$129.09K
3.1%
NMRA
Neumora Therapeutics, Inc.
17 Sep 2024
Head of R&D
Sold on a plan
30,788
$363.74K
8.3%
NMRA
Neumora Therapeutics, Inc.
12 Sep 2024
Head of R&D
Sold on a plan
32,948
$376.66K
8.2%
6 decisions on file.
